BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 96 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,914 | -9.7% | 14,845 | +2.9% | 0.00% | -50.0% |
| Q2 2023 | $236,990 | +0.9% | 14,433 | +2.7% | 0.00% | 0.0% |
| Q1 2023 | $234,798 | -42.9% | 14,052 | -48.6% | 0.00% | 0.0% |
| Q4 2022 | $411,494 | +3.5% | 27,362 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $397,687 | +87.5% | 26,616 | +106.2% | 0.00% | -20.0% |
| Q2 2022 | $212,051 | -15.9% | 12,906 | +2.6% | 0.01% | -16.7% |
| Q1 2022 | $252,000 | -19.2% | 12,577 | +2.2% | 0.01% | -25.0% |
| Q4 2021 | $312,000 | -4.3% | 12,303 | +2.0% | 0.01% | -20.0% |
| Q3 2021 | $326,000 | -5.0% | 12,065 | +1.6% | 0.01% | 0.0% |
| Q2 2021 | $343,000 | +11.4% | 11,877 | +1.6% | 0.01% | 0.0% |
| Q1 2021 | $308,000 | -6.9% | 11,695 | +1.3% | 0.01% | -28.6% |
| Q4 2020 | $331,000 | – | 11,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |